ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1514

Self-referral Strategy for Early Diagnosis of Axial Spondyloarthritis- Preliminary Analysis from Finding Axial Spondyloarthritis Study

Abhijeet Danve, Yale University, New Haven, CT

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Cohort Study, informatics, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Lack of timely rheumatology referral for suspected axial spondyloarthritis (axSpA) is a major contributor to delayed diagnosis in patients with chronic back pain (CBP). Poor disease awareness among non-rheumatologists and busy practice patterns adversely affect referral process. In this study we evaluated the effectiveness of a self-referral strategy using an online screening tool distributed to at risk patients using electronic medical record and social media.

Methods: Based on the predictive values of spondyloarthritis features, we developed a screening tool (A-tool) consisting of a 3 question prescreen and 8 question screening questionnaire (SQ). A-tool was distributed via patient portal (Mychart) to patients age 18 to 65 years who had CBP listed as a medical problem in their electronic medical record and also via Facebook to general population in our geographical area. Patients who passed all 3 questions in pre-screen could access the SQ and those with 3 or more positive responses on SQ were invited for study visit after confirming the eligibility. Patients with known diagnosis of axSpA, age >65 yr and previous spine surgery were excluded. Patients underwent history and physical, labs (CRP and HLA-B27) and imaging studies (X-ray and MRI of pelvis). Clinician’s judgement was considered gold standard for diagnosis of axSpA. DNA and plasma samples have been stored for biomarker research. Statistical analysis was done with descriptive statistics, logistic regression, T-test and chi-square tests.

Results: Total 1289 patients took the survey through MyChart (51%) or Facebook (49%) from April 2019 to February 2022 (Table 1). Among the responders, 851 (66%) had positive pre-screen and 653 (51%) had positive A-tool. As of May 2022, 100 patients were enrolled of which 84 patients completed a study visit, labs and imaging. Remaining 16 did not complete labs or imaging studies after the study visit. Out of 84 patients, 28 (33%) were diagnosed with axSpA. There were 7 patients with AS and 21 with nr-axSpA. Predictive values of individual questions in the A-tool are described in Table 3. Further analysis of data is underway.

Conclusion: Our findings suggest that A-tool based self-referral strategy for early diagnosis of axSpA among patients with CBP is practical and feasible approach. Combination of SpA features may be more useful for referral as compared to individual features. We need larger prospective study to validate our findings.

Supporting image 1

Table 1. Patient Flow Chart

Supporting image 2

Table 2. Response to A-tool Questions

Supporting image 3

Characteristics of Individual Questions within the A-tool


Disclosures: A. Danve, AbbVie/Abbott, Amgen, Janssen, Novartis.

To cite this abstract in AMA style:

Danve A. Self-referral Strategy for Early Diagnosis of Axial Spondyloarthritis- Preliminary Analysis from Finding Axial Spondyloarthritis Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/self-referral-strategy-for-early-diagnosis-of-axial-spondyloarthritis-preliminary-analysis-from-finding-axial-spondyloarthritis-study-2/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-referral-strategy-for-early-diagnosis-of-axial-spondyloarthritis-preliminary-analysis-from-finding-axial-spondyloarthritis-study-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology